Trial Profile
Phase I study of palifosfamide in combination with standard care in patients with small cell lung cancer.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Aug 2022
Price :
$35
*
At a glance
- Drugs Palifosfamide (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions
- 05 May 2011 Status changed from planning to recruiting.
- 29 Sep 2010 New trial record